Saturday 17 October 2026
Export GEHC’s income statement to Excel — free account
GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.
69.57
0.78
−1.11%
Follow GEHC
| Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
P/E ratio |
13.06 | 13.06 | 13.06 | 13.06 | 25.04 | 17.89 | 17.99 |
Piotroski F-Score |
— | — | — | 5 | 5 | 5 | 4 |
Altman Z-Score |
— | — | — | — | 1.76 | 1.88 | 1.96 |
P/S ratio |
0.00 | 0.00 | 0.00 | 1.39 | 1.78 | 1.81 | 1.81 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | 1.02 | 1.28 | 1.98 |
P/FCF ratio |
36.03 | 36.03 | 36.03 | 13.91 | 20.26 | 22.94 | 24.85 |
P/Operating CF |
43.79 | 43.79 | 43.79 | 23.92 | 33.09 | 39.05 | 35.62 |
Beneish M-Score |
— | — | (1.85) | (2.87) | (2.48) | (2.46) | (2.33) |
P/B ratio |
1.61 | 1.61 | 1.61 | 2.72 | 4.86 | 4.21 | 3.60 |
Dividend Safety Score |
— | — | — | — | — | — | 74 |
Price to Tangible BV |
10.84 | 10.84 | 10.84 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 1.76 | 2.21 | 2.20 | 2.16 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 10.21 | 14.19 | 13.49 | 13.34 |
EV/Operating CF |
25.27 | 25.27 | 25.27 | 15.10 | 20.56 | 22.11 | 22.42 |
EV/FCF |
35.43 | 35.43 | 35.43 | 17.63 | 25.19 | 27.82 | 29.61 |
Quick Ratio |
— | 0.47 | 0.56 | 0.66 | 0.67 | 0.68 | 0.93 |
Current Ratio |
— | 0.90 | 1.04 | 1.16 | 1.05 | 1.04 | 1.37 |
Net Debt/EBITDA |
0.00 | (0.29) | (0.15) | 2.16 | 2.78 | 2.37 | 2.14 |
Debt/Assets |
0.00% | 0.14% | 0.14% | 29.95% | 33.77% | 31.65% | 31.62% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.88 | 1.53 | 1.24 | 1.12 |
Asset Turnover |
0.00 | 1.42 | 0.70 | 0.68 | 0.65 | 0.60 | 0.59 |
Operating CF/Net income |
1.21 | 0.19 | 0.72 | 1.11 | 1.52 | 0.98 | 0.95 |
Capex/Depreciation |
(0.42) | (0.39) | (0.37) | (0.48) | (0.63) | (0.69) | (0.83) |
| 0.00% | 0.00% | 14.30% | 14.72% | 16.78% | 25.54% | 22.11% | |
| 0.00% | 114.30% | 8.89% | 7.12% | 4.62% | 6.08% | 5.95% | |
ROIC |
0.00% | 12.34% | 10.81% | 9.75% | 9.75% | 10.22% | 9.84% |
Return on Tangible Assets |
0.00% | 1,184.43% | 90.82% | 55.68% | 47.29% | 68.77% | 32.12% |
Average Days of Receivables |
0.00 | 43.68 | 67.64 | 65.91 | 66.40 | 66.16 | 69.99 |
Research and Development Expense of Revenue |
5.01% | 4.72% | 4.64% | 5.59% | 6.16% | 6.66% | 6.11% |
Selling, General and Administrative Expense of Revenue |
21.59% | 18.86% | 20.26% | 19.80% | 21.90% | 21.70% | 20.48% |
Intangible Assets out of Total Assets |
0.00 | 0.56 | 0.56 | 0.52 | 0.44 | 0.43 | 0.40 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.43% | 0.37% | 0.58% | 0.64% | 0.63% |
Graham Net Nets |
(0.07) | (0.07) | (0.07) | (0.39) | (0.46) | (0.41) | (0.37) |
Graham Number |
0.00 | 0.00 | 0.00 | 44.61 | 32.83 | 42.72 | 48.35 |
Earnings Yield |
7.66% | 7.66% | 7.66% | 7.66% | 3.99% | 5.59% | 5.56% |
Free Cash Flow Yield |
2.78% | 2.78% | 2.78% | 7.19% | 4.94% | 4.36% | 4.02% |
Revenue per Share |
36.56 | 37.72 | 38.73 | 40.40 | 42.97 | 43.14 | 45.23 |
Operating CF per Share |
4.04 | 5.75 | 3.54 | 4.70 | 4.62 | 4.29 | 4.36 |
Capex per Share |
(0.61) | (0.53) | (0.51) | (0.67) | (0.85) | (0.88) | (1.06) |
Free Cash Flow per Share |
3.43 | 5.22 | 3.03 | 4.03 | 3.77 | 3.41 | 3.30 |
Cash per Share |
0.00 | 2.21 | 1.22 | 3.18 | 5.50 | 6.34 | 9.89 |
Shareholders Equity per Share |
0.00 | 32.42 | 36.73 | 20.62 | 15.70 | 18.56 | 22.79 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 32.42 | 36.73 | 20.62 | 15.70 | 18.56 | 22.79 |
Free Cash Flow |
1,559.00 | 2,375.00 | 1,374.00 | 1,828.00 | 1,715.00 | 1,554.00 | 1,505.00 |
Working Capital |
— | (628.00) | 239.00 | 1,127.00 | 429.00 | 348.00 | 3,396.00 |
Capital Expenditures |
(279.00) | (243.00) | (233.00) | (306.00) | (386.00) | (401.00) | (482.00) |
Net Current Asset Value |
0.00 | (3,581.00) | (2,632.00) | (9,859.00) | (15,899.00) | (14,724.00) | (14,015.00) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 12.78 | 17.74 | 16.47 | 16.13 |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 10.08 | 14.27 | 13.58 | 13.54 |
| Other line items | |||||||
Depreciation/Fixed assets |
0.00 | 0.35 | 0.28 | 0.27 | 0.24 | 0.23 | 0.19 |
Cash ROIC |
0.00% | 15.04% | 7.96% | 9.59% | 8.32% | 7.12% | 5.66% |
Accounts Receivable Turnover |
0.00 | 0.00 | 6.62 | 5.58 | 5.69 | 5.52 | 5.48 |
Accounts Payable Turnover |
0.00 | 0.00 | 4.43 | 4.07 | 3.95 | 3.83 | 3.94 |
Inventory Turnover |
0.00 | 0.00 | 5.88 | 5.44 | 5.65 | 5.88 | 5.93 |
Average Days of Payables |
0.00 | 75.90 | 89.05 | 96.27 | 92.49 | 96.61 | 95.84 |
Days of Inventory on Hand |
0.00 | 55.96 | 68.23 | 70.47 | 61.51 | 61.72 | 65.88 |
Average Receivables |
— | — | 2,656.50 | 3,285.50 | 3,434.50 | 3,561.50 | 3,760.50 |
Average Payables |
— | — | 2,351.00 | 2,742.00 | 2,945.50 | 2,991.00 | 3,142.50 |
Average Inventory |
— | — | 1,770.00 | 2,050.50 | 2,057.50 | 1,949.50 | 2,086.50 |
Average Assets |
— | 12,114.00 | 25,268.00 | 26,923.50 | 29,996.50 | 32,771.50 | 34,997.50 |
Average Common Equity |
— | — | 15,713.50 | 13,019.00 | 8,253.50 | 7,804.50 | 9,427.50 |
Columns are period end dates